ICD-10-CM Billable Code

R82.5

Elevated urine levels of drugs, medicaments and biological substances

Clinical Classification Guidelines

Inclusion Terms

  • Elevated urine levels of catecholamines
  • Elevated urine levels of indoleacetic acid
  • Elevated urine levels of 17-ketosteroids
  • Elevated urine levels of steroids

Medical Intelligence & Overview

ICD-10 code R82.5 refers to the presence of elevated levels of certain substances in urine, including drugs, medications, and biological compounds. This condition can be detected through laboratory testing and may provide important information about a person's metabolic state or medication use. Elevations in these substances can have various underlying causes and may reflect physiological changes, medication responses, or specific health conditions.

Causes & Symptoms

Clinical Causes: Use of prescribed medications such as steroids, catecholamines, or other drugs metabolized and excreted via urine Hormonal disorders leading to increased production or decreased clearance of biological substances like 17-ketosteroids and indoleacetic acid Metabolic conditions affecting steroid or catecholamine metabolism Certain tumors or neoplasms producing excess biological substances Dietary factors or supplements that influence urinary substance levels Kidney or urinary tract conditions impacting excretion of substances

Key Symptoms: No specific symptoms directly associated with elevated urine levels; findings are typically incidental during lab testing Possible indications of underlying conditions, such as hormonal imbalances or metabolic disorders Potential signs related to the underlying cause, such as hormonal symptoms or metabolic disturbances

Diagnostic & Treatment

Diagnosis Path: The diagnosis is primarily established through laboratory urine tests that measure the levels of specific substances. These tests evaluate substances like catecholamines, indoleacetic acid, 17-ketosteroids, and steroids. Additional assessments may include blood tests, imaging, or biopsies to determine underlying causes and associated conditions.

Treatment Protocols: Management depends on the identified underlying cause. Treatment options may include adjusting or discontinuing certain medications, addressing hormonal imbalances, or treating metabolic disorders. Regular monitoring of urine substance levels can help track response to treatment and guide further interventions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R82.5 a billable ICD-10 code?
Yes, R82.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R82.5?
Clinical documentation must specify the nature of Elevated urine levels of drugs, medicaments and biological substances and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

medicaments substances urine elevated levels biological